The Cole Eye Institute Imaging Summit took place on Thursday, August 10, 2017 prior to the American Society of Retina Specialists (ASRS).
The is a CME symposium focusing on new advances in OCT imaging with hands-on imaging sessions. Attendees will be able to discuss current topics in tomography and imaging with a faculty of distinguished peers. Ocular imaging technology is an area of intense innovation with every year bringing better and more options to the clinic. Outcomes in vision care are best when ophthalmologists, retina specialists, and other eye care health practicioners remain informed of the latest ocular imaging capabilities. Following this course, learners will be able to better select appropriate diagnostic testing and better interpret those tests to improve patient care. Additionally, learners will be made aware of new and exciting modalities of ophthalmic imaging that can be implemented into their clinical practice.
-My Approach to Imaging in Diabetic Retinopathy
Barbara A. Blodi, MD
-Defining Ischemia in Retinal Vascular Disease: OCT-A or FA?
Nadia K. Waheed, MD, MPH
-How Does Imaging in RVO Guide My Clinical Decision-Making?
Aleksandra Rachitskaya, MD
-Panel Discussion: Retinal Vascular Disease Imaging
Moderator: Justis P. Ehlers, MD
Release Date: October 10, 2017
Expiration Date: October 10, 2018
The Cole Eye Institute Imaging Summit is for comprehensive ophthalmologists, retina specialists, retina fellows and healthcare providers who are interested in applying the most current, cutting-edge OCT imaging knowledge, including emerging techniques for imaging and treating retinal diseases.
Upon completion of the educational activity, participants should be able to:
In order to receive credit, participants should watch the entire video. Statements of credit will be awarded upon successful completion of the quiz and online evaluation/claim credit form. If you have questions about this CME activity, please contact AKH Inc. at firstname.lastname@example.org
CME Credit provided by AKH Inc., Advancing Knowledge in Healthcare
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and MCME Global, Inc. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.
AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.
Dorothy Caputo, MA, BSN, RN- CE Director of Accreditations
MCME Global Staff and Planners
AKH Staff and Planners
This activity is supported by an educational grant from Alcon, Genentech, Regeneron Pharmaceuticals, Inc. and Santen Pharmaceutical Co., Ltd.
Barbara Blodi, MD
Justis P. Ehlers, MD
Aleksandra Rachitskaya, MD
Nadia K. Waheed, MD
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Author Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other author for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.